Detalhe da pesquisa
1.
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.
N Engl J Med
; 389(24): 2256-2266, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870955
2.
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
N Engl J Med
; 386(1): 24-34, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34986285
3.
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Lancet Oncol
; 25(4): 509-517, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547894
4.
New Sarculator Prognostic Nomograms for Patients With Primary Retroperitoneal Sarcoma: Case Volume Does Matter.
Ann Surg
; 279(5): 857-865, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37753660
5.
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
N Engl J Med
; 385(13): 1196-1206, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551229
6.
Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C melanoma is removed by surgery.
Future Oncol
; 20(15): 959-968, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38390818
7.
MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in Chondrosarcoma.
Int J Mol Sci
; 25(6)2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38542153
8.
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study.
Lancet Oncol
; 24(1): 33-44, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460017
9.
Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results.
Ann Surg
; 278(1): 127-134, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833413
10.
Retrospective Analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas: An International Study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
Ann Surg
; 278(2): 267-273, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35866666
11.
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
Lancet
; 399(10336): 1718-1729, 2022 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367007
12.
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma.
Br J Surg
; 110(7): 818-830, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131298
13.
Molecular Aspects of a Diet as a New Pathway in the Prevention and Treatment of Alzheimer's Disease.
Int J Mol Sci
; 24(13)2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445928
14.
Epigenetic Abnormalities in Chondrosarcoma.
Int J Mol Sci
; 24(5)2023 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36901967
15.
MEETING HIGHLIGHTS: THE THIRD MARIE SKLODOWSKA-CURIE SYMPOSIUM ON CANCER RESEARCH AND CARE AT ROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, SEPTEMBER 20-22, 2023.
Wiad Lek
; 76(12): 2543-2555, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290016
16.
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial.
Lancet Oncol
; 23(11): 1378-1388, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265502
17.
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
N Engl J Med
; 381(7): 626-636, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31166680
18.
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
N Engl J Med
; 381(16): 1535-1546, 2019 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562797
19.
Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence.
Cancer Immunol Immunother
; 71(8): 1949-1958, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35075516
20.
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
J Transl Med
; 20(1): 200, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538491